首页> 外文期刊>Chimica oggi: international journal of chemistry and biotechnology >Newly discovered human peptide may become a new treatment for diabetes
【24h】

Newly discovered human peptide may become a new treatment for diabetes

机译:新发现的人肽可能成为糖尿病的新疗法

获取原文
获取原文并翻译 | 示例
           

摘要

New research in The FASEB Journal suggests that humanin, a peptide produced by the human body, increases the metabolism of glucose in beta cells, which in turn markedly increases insulin secretion. Even if the obesity trend cannot be reversed, here's hope that it's partner in crime-diabetes-might be thwarted. New research published in the December 2013 issue of The FASEB Journal shows how a recently discovered human peptide, called humanin, could lead to powerful new treatments for some people living with diabetes. That's because research in mice and rats shows that a humanin analogue (a peptide molecularly similar to humanin) increases insulin secretion leading to an increase in glucose metabolism within beta cells. "Diabetes is a major disease that is expected to affect more than 500 million people in the next two decades," said Radhika Muzumdar, M.D., study author from the Departments of Pediatrics and Medicine in the Divisions of Endocrinology and Geriatrics at Children's Hospital at Montefiore at the Albert Einstein College of Medicine in Bronx, New York. "Humanin could be a potential weapon in our arsenal in the fight against this global problem."
机译:《 FASEB杂志》上的新研究表明,人体产生的肽类人源蛋白可增加β细胞中葡萄糖的代谢,进而显着增加胰岛素的分泌。即使肥胖趋势无法逆转,也希望它可能成为犯罪糖尿病的伴侣。 2013年12月出版的《 FASEB杂志》上发表了一项新研究,该研究表明,最近发现的人类肽,称为人源素,可以为某些糖尿病患者带来强有力的新疗法。这是因为在小鼠和大鼠中的研究表明,人源蛋白类似物(一种与人源蛋白分子相似的肽)可增加胰岛素分泌,从而导致β细胞内葡萄糖代谢增加。蒙特菲奥雷儿童医院内分泌科和老年医学科的研究作者Radhika Muzumdar医学博士说:“糖尿病是一种主要疾病,预计将在未来二十年内影响超过5亿人。”在纽约布朗克斯的阿尔伯特·爱因斯坦医学院。 “人类素可能是我们解决这一全球问题的武器库中的潜在武器。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号